Eric P. Zorrilla - Publications

Affiliations: 
Scripps Research Institute 
 University of California, San Diego, La Jolla, CA 

117 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Cruz B, Vozella V, Borgonetti V, Bullard R, Bianchi PC, Kirson D, Bertotto LB, Bajo M, Vlkolinsky R, Messing RO, Zorrilla EP, Roberto M. Chemogenetic inhibition of central amygdala CRF-expressing neurons decreases alcohol intake but not trauma-related behaviors in a rat model of post-traumatic stress and alcohol use disorder. Molecular Psychiatry. PMID 38509197 DOI: 10.1038/s41380-024-02514-8  0.331
2024 Bertotto LB, Lampson-Stixrud D, Sinha A, Rohani NK, Myer I, Zorrilla EP. Effects of the Phosphodiesterase 10A Inhibitor MR1916 on Alcohol Self-Administration and Striatal Gene Expression in Post-Chronic Intermittent Ethanol-Exposed Rats. Cells. 13. PMID 38391934 DOI: 10.3390/cells13040321  0.356
2022 Laque A, Wagner GE, Matzeu A, De Ness GL, Kerr TM, Carroll AM, de Guglielmo G, Nedelescu H, Buczynski MW, Gregus AM, Jhou TC, Zorrilla EP, Martin-Fardon R, Koya E, Ritter RC, et al. Linking drug and food addiction via compulsive appetite. British Journal of Pharmacology. PMID 35023154 DOI: 10.1111/bph.15797  0.443
2021 Vozella V, Cruz B, Natividad LA, Benvenuti F, Cannella N, Edwards S, Zorrilla EP, Ciccocioppo R, Roberto M. Glucocorticoid Receptor Antagonist Mifepristone Does Not Alter Innate Anxiety-Like Behavior in Genetically-Selected Marchigian Sardinian (msP) Rats. International Journal of Molecular Sciences. 22. PMID 33803557 DOI: 10.3390/ijms22063095  0.561
2020 Okhuarobo A, Bolton JL, Igbe I, Zorrilla EP, Baram TZ, Contet C. A novel mouse model for vulnerability to alcohol dependence induced by early-life adversity. Neurobiology of Stress. 13: 100269. PMID 33344722 DOI: 10.1016/j.ynstr.2020.100269  0.695
2020 Steinman MQ, Kirson D, Wolfe SA, Khom S, D'Ambrosio SR, Spierling Bagsic SR, Bajo M, Vlkolinský R, Hoang NK, Singhal A, Sureshchandra S, Oleata CS, Messaoudi I, Zorrilla EP, Roberto M. Importance of sex and trauma context on circulating cytokines and amygdalar GABAergic signaling in a comorbid model of posttraumatic stress and alcohol use disorders. Molecular Psychiatry. PMID 33087855 DOI: 10.1038/s41380-020-00920-2  0.304
2019 Spierling S, de Guglielmo G, Kirson D, Kreisler A, Roberto M, George O, Zorrilla EP. Insula to ventral striatal projections mediate compulsive eating produced by intermittent access to palatable food. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31593982 DOI: 10.1038/S41386-019-0538-X  0.655
2019 Zorrilla EP, Koob GF. Corrigendum: Impulsivity Derived From the Dark Side: Neurocircuits That Contribute to Negative Urgency. Frontiers in Behavioral Neuroscience. 13: 188. PMID 31501652 DOI: 10.3389/fnbeh.2019.00188  0.49
2019 Zorrilla EP, Koob GF. Impulsivity Derived From the Dark Side: Neurocircuits That Contribute to Negative Urgency. Frontiers in Behavioral Neuroscience. 13: 136. PMID 31293401 DOI: 10.3389/fnbeh.2019.00136  0.57
2018 Kreisler AD, Mattock M, Zorrilla EP. The duration of intermittent access to preferred sucrose-rich food affects binge-like intake, fat accumulation, and fasting glucose in male rats. Appetite. 130: 59-69. PMID 30063959 DOI: 10.1016/j.appet.2018.07.025  0.431
2018 Serrano A, Pavon FJ, Buczynski MW, Schlosburg J, Natividad LA, Polis IY, Stouffer DG, Zorrilla EP, Roberto M, Cravatt BF, Martin-Fardon R, Rodriguez de Fonseca F, Parsons LH. Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intake. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29748627 DOI: 10.1038/S41386-018-0055-3  0.794
2018 Spierling SR, Kreisler AD, Williams CA, Fang SY, Pucci SN, Kines KT, Zorrilla EP. Intermittent, extended access to preferred food leads to escalated food reinforcement and cyclic whole-body metabolism in rats: Sex differences and individual vulnerability. Physiology & Behavior. PMID 29654812 DOI: 10.1016/j.physbeh.2018.04.001  0.417
2018 Logrip ML, Walker JR, Ayanwuyi LO, Sabino V, Ciccocioppo R, Koob GF, Zorrilla EP. Evaluation of Alcohol Preference and Drinking in msP Rats Bearing aPromoter Polymorphism. Frontiers in Psychiatry. 9: 28. PMID 29497387 DOI: 10.3389/Fpsyt.2018.00028  0.817
2018 Rupprecht LE, Kreisler AD, Spierling SR, de Guglielmo G, Kallupi M, George O, Donny EC, Zorrilla EP, Sved AF. Self-administered nicotine increases fat metabolism and suppresses weight gain in male rats. Psychopharmacology. PMID 29354872 DOI: 10.1007/S00213-018-4830-Y  0.605
2017 Roberto M, Spierling SR, Kirson D, Zorrilla EP. Corticotropin-Releasing Factor (CRF) and Addictive Behaviors. International Review of Neurobiology. 136: 5-51. PMID 29056155 DOI: 10.1016/Bs.Irn.2017.06.004  0.36
2017 Kimbrough A, de Guglielmo G, Kononoff J, Kallupi M, Zorrilla EP, George O. CRF1 receptor-dependent increases in irritability-like behavior during abstinence from chronic intermittent ethanol vapor exposure. Alcoholism, Clinical and Experimental Research. PMID 28833238 DOI: 10.1111/Acer.13484  0.617
2017 Somkuwar SS, Vendruscolo LF, Fannon MJ, Schmeichel BE, Nguyen TB, Guevara J, Sidhu H, Contet C, Zorrilla EP, Mandyam CD. Abstinence from prolonged ethanol exposure affects plasma corticosterone, glucocorticoid receptor signaling and stress-related behaviors. Psychoneuroendocrinology. 84: 17-31. PMID 28647675 DOI: 10.1016/J.Psyneuen.2017.06.006  0.733
2017 Spierling SR, Mattock M, Zorrilla EP. Modeling hypohedonia following repeated social defeat: Individual vulnerability and dopaminergic involvement. Physiology & Behavior. PMID 28433467 DOI: 10.1016/j.physbeh.2017.04.016  0.41
2017 Kreisler AD, Garcia MG, Spierling SR, Hui BE, Zorrilla EP. Extended vs. brief intermittent access to palatable food differently promote binge-like intake, rejection of less preferred food, and weight cycling in female rats. Physiology & Behavior. PMID 28366814 DOI: 10.1016/j.physbeh.2017.03.039  0.388
2017 Spierling SR, Zorrilla EP. Don't stress about CRF: assessing the translational failures of CRF1antagonists. Psychopharmacology. PMID 28265716 DOI: 10.1007/s00213-017-4556-2  0.335
2017 Kreisler A, Zorrilla E. Extended vs. brief intermittent access to palatable food differently promote binge-like intake and rejection of less preferred food in female rats Drug and Alcohol Dependence. 171: e111. DOI: 10.1016/j.drugalcdep.2016.08.310  0.385
2014 Logrip ML, Zorrilla EP. Differential changes in amygdala and frontal cortex Pde10a expression during acute and protracted withdrawal. Frontiers in Integrative Neuroscience. 8: 30. PMID 24782725 DOI: 10.3389/fnint.2014.00030  0.739
2014 Logrip ML, Vendruscolo LF, Schlosburg JE, Koob GF, Zorrilla EP. Phosphodiesterase 10A regulates alcohol and saccharin self-administration in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1722-31. PMID 24549104 DOI: 10.1038/Npp.2014.20  0.82
2014 Zorrilla EP, Logrip ML, Koob GF. Corticotropin releasing factor: a key role in the neurobiology of addiction. Frontiers in Neuroendocrinology. 35: 234-44. PMID 24456850 DOI: 10.1016/j.yfrne.2014.01.001  0.783
2013 Zorrilla EP, Roberts AJ, Rivier JE, Koob GF. Anxiolytic-like effects of antisauvagine-30 in mice are not mediated by CRF2 receptors. Plos One. 8: e63942. PMID 24015170 DOI: 10.1371/journal.pone.0063942  0.621
2013 Blasio A, Iemolo A, Sabino V, Petrosino S, Steardo L, Rice KC, Orlando P, Iannotti FA, Di Marzo V, Zorrilla EP, Cottone P. Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2498-507. PMID 23793355 DOI: 10.1038/Npp.2013.153  0.808
2013 Cottone P, Sabino V, Nagy TR, Coscina DV, Levin BE, Zorrilla EP. Centrally administered urocortin 2 decreases gorging on high-fat diet in both diet-induced obesity-prone and -resistant rats. International Journal of Obesity (2005). 37: 1515-23. PMID 23478425 DOI: 10.1038/Ijo.2013.22  0.811
2013 Zorrilla EP, Heilig M, de Wit H, Shaham Y. Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism. Drug and Alcohol Dependence. 128: 175-86. PMID 23294766 DOI: 10.1016/J.Drugalcdep.2012.12.017  0.586
2013 Zorrilla EP, Koob GF. Amygdalostriatal projections in the neurocircuitry for motivation: a neuroanatomical thread through the career of Ann Kelley. Neuroscience and Biobehavioral Reviews. 37: 1932-45. PMID 23220696 DOI: 10.1016/j.neubiorev.2012.11.019  0.54
2012 Parylak SL, Cottone P, Sabino V, Rice KC, Zorrilla EP. Effects of CB1 and CRF1 receptor antagonists on binge-like eating in rats with limited access to a sweet fat diet: lack of withdrawal-like responses. Physiology & Behavior. 107: 231-42. PMID 22776620 DOI: 10.1016/J.Physbeh.2012.06.017  0.831
2012 Logrip ML, Zorrilla EP. Stress history increases alcohol intake in relapse: relation to phosphodiesterase 10A. Addiction Biology. 17: 920-33. PMID 22741603 DOI: 10.1111/j.1369-1600.2012.00460.x  0.756
2012 Vendruscolo LF, Barbier E, Schlosburg JE, Misra KK, Whitfield TW, Logrip ML, Rivier C, Repunte-Canonigo V, Zorrilla EP, Sanna PP, Heilig M, Koob GF. Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 7563-71. PMID 22649234 DOI: 10.1523/Jneurosci.0069-12.2012  0.805
2012 Koob GF, Zorrilla EP. Update on corticotropin-releasing factor pharmacotherapy for psychiatric disorders: a revisionist view. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 308-9. PMID 22157874 DOI: 10.1038/npp.2011.213  0.609
2012 Zakhari JS, Zorrilla EP, Zhou B, Mayorov AV, Janda KD. Oligoclonal antibody targeting ghrelin increases energy expenditure and reduces food intake in fasted mice. Molecular Pharmaceutics. 9: 281-9. PMID 22149064 DOI: 10.1021/Mp200376C  0.354
2012 Logrip ML, Zorrilla EP, Koob GF. Stress modulation of drug self-administration: implications for addiction comorbidity with post-traumatic stress disorder. Neuropharmacology. 62: 552-64. PMID 21782834 DOI: 10.1016/j.neuropharm.2011.07.007  0.755
2012 Zorrilla EP, Wee S, Zhao Y, Specio S, Boutrel B, Koob GF, Weiss F. Extended access cocaine self-administration differentially activates dorsal raphe and amygdala corticotropin-releasing factor systems in rats. Addiction Biology. 17: 300-8. PMID 21762287 DOI: 10.1111/J.1369-1600.2011.00329.X  0.793
2011 Fekete EM, Zhao Y, Szücs A, Sabino V, Cottone P, Rivier J, Vale WW, Koob GF, Zorrilla EP. Systemic urocortin 2, but not urocortin 1 or stressin 1-A, suppresses feeding via CRF2 receptors without malaise and stress. British Journal of Pharmacology. 164: 1959-75. PMID 21627635 DOI: 10.1111/J.1476-5381.2011.01512.X  0.804
2011 Parylak SL, Koob GF, Zorrilla EP. The dark side of food addiction. Physiology & Behavior. 104: 149-56. PMID 21557958 DOI: 10.1016/J.Physbeh.2011.04.063  0.614
2011 Logrip ML, Koob GF, Zorrilla EP. Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention. Cns Drugs. 25: 271-87. PMID 21425881 DOI: 10.2165/11587790-000000000-00000  0.772
2011 Sabino V, Cottone P, Blasio A, Iyer MR, Steardo L, Rice KC, Conti B, Koob GF, Zorrilla EP. Activation of σ-receptors induces binge-like drinking in Sardinian alcohol-preferring rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1207-18. PMID 21346735 DOI: 10.1038/Npp.2011.5  0.825
2011 Walker BM, Zorrilla EP, Koob GF. Systemic κ-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats. Addiction Biology. 16: 116-9. PMID 20579007 DOI: 10.1111/j.1369-1600.2010.00226.x  0.765
2010 Repunte-Canonigo V, van der Stap LD, Chen J, Sabino V, Wagner U, Zorrilla EP, Schumann G, Roberts AJ, Sanna PP. Genome-wide gene expression analysis identifies K-ras as a regulator of alcohol intake. Brain Research. 1339: 1-10. PMID 20388501 DOI: 10.1016/j.brainres.2010.03.063  0.646
2010 Zorrilla EP, Koob GF. Progress in corticotropin-releasing factor-1 antagonist development. Drug Discovery Today. 15: 371-83. PMID 20206287 DOI: 10.1016/j.drudis.2010.02.011  0.604
2010 Roberto M, Cruz MT, Gilpin NW, Sabino V, Schweitzer P, Bajo M, Cottone P, Madamba SG, Stouffer DG, Zorrilla EP, Koob GF, Siggins GR, Parsons LH. Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence. Biological Psychiatry. 67: 831-9. PMID 20060104 DOI: 10.1016/J.Biopsych.2009.11.007  0.791
2010 Koob GF, Zorrilla EP. Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor. Current Opinion in Investigational Drugs (London, England : 2000). 11: 63-71. PMID 20047160  0.528
2010 Martin-Fardon R, Zorrilla EP, Ciccocioppo R, Weiss F. Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin. Brain Research. 1314: 145-61. PMID 20026088 DOI: 10.1016/J.Brainres.2009.12.027  0.523
2010 Fekete EM, Zorrilla EP. Urocortins Encyclopedia of Stress. 804-811. DOI: 10.1016/B978-012373947-6.00386-X  0.733
2009 Cottone P, Sabino V, Roberto M, Bajo M, Pockros L, Frihauf JB, Fekete EM, Steardo L, Rice KC, Grigoriadis DE, Conti B, Koob GF, Zorrilla EP. CRF system recruitment mediates dark side of compulsive eating. Proceedings of the National Academy of Sciences of the United States of America. 106: 20016-20. PMID 19901333 DOI: 10.1073/Pnas.0908789106  0.805
2009 Fonareva I, Spangler E, Cannella N, Sabino V, Cottone P, Ciccocioppo R, Zorrilla EP, Ryabinin AE. Increased perioculomotor urocortin 1 immunoreactivity in genetically selected alcohol preferring rats. Alcoholism, Clinical and Experimental Research. 33: 1956-65. PMID 19673740 DOI: 10.1111/J.1530-0277.2009.01033.X  0.816
2009 Sabino V, Cottone P, Zhao Y, Steardo L, Koob GF, Zorrilla EP. Selective reduction of alcohol drinking in Sardinian alcohol-preferring rats by a sigma-1 receptor antagonist. Psychopharmacology. 205: 327-35. PMID 19440699 DOI: 10.1007/S00213-009-1548-X  0.819
2009 Szabadfi K, Atlasz T, Reglodi D, Kiss P, Dányádi B, Fekete EM, Zorrilla EP, Tamás A, Szabó K, Gábriel R. Urocortin 2 protects against retinal degeneration following bilateral common carotid artery occlusion in the rat. Neuroscience Letters. 455: 42-5. PMID 19429103 DOI: 10.1016/j.neulet.2009.03.013  0.748
2009 Francesconi W, Berton F, Repunte-Canonigo V, Hagihara K, Thurbon D, Lekic D, Specio SE, Greenwell TN, Chen SA, Rice KC, Richardson HN, O'Dell LE, Zorrilla EP, Morales M, Koob GF, et al. Protracted withdrawal from alcohol and drugs of abuse impairs long-term potentiation of intrinsic excitability in the juxtacapsular bed nucleus of the stria terminalis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 5389-401. PMID 19403807 DOI: 10.1523/Jneurosci.5129-08.2009  0.817
2009 Fekete EM, Zhao Y, Li C, Sabino V, Vale WW, Zorrilla EP. Social defeat stress activates medial amygdala cells that express type 2 corticotropin-releasing factor receptor mRNA. Neuroscience. 162: 5-13. PMID 19358876 DOI: 10.1016/J.Neuroscience.2009.03.078  0.802
2009 Greenwell TN, Funk CK, Cottone P, Richardson HN, Chen SA, Rice KC, Zorrilla EP, Koob GF. Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats. Addiction Biology. 14: 130-43. PMID 19291009 DOI: 10.1111/j.1369-1600.2008.00142.x  0.806
2009 Nie Z, Zorrilla EP, Madamba SG, Rice KC, Roberto M, Siggins GR. Presynaptic CRF1 receptors mediate the ethanol enhancement of GABAergic transmission in the mouse central amygdala. Thescientificworldjournal. 9: 68-85. PMID 19151899 DOI: 10.1100/Tsw.2009.1  0.431
2009 Sabino V, Cottone P, Parylak SL, Steardo L, Zorrilla EP. Sigma-1 receptor knockout mice display a depressive-like phenotype. Behavioural Brain Research. 198: 472-6. PMID 19100292 DOI: 10.1016/J.Bbr.2008.11.036  0.774
2009 Sabino V, Cottone P, Zhao Y, Iyer MR, Steardo L, Steardo L, Rice KC, Conti B, Koob GF, Zorrilla EP. The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1482-93. PMID 18946467 DOI: 10.1038/Npp.2008.192  0.817
2009 Cottone P, Sabino V, Steardo L, Zorrilla EP. Consummatory, anxiety-related and metabolic adaptations in female rats with alternating access to preferred food. Psychoneuroendocrinology. 34: 38-49. PMID 18842344 DOI: 10.1016/j.psyneuen.2008.08.010  0.816
2009 Greenwell TN, Walker BM, Cottone P, Zorrilla EP, Koob GF. The alpha1 adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administration. Pharmacology, Biochemistry, and Behavior. 91: 295-302. PMID 18703080 DOI: 10.1016/j.pbb.2008.07.012  0.806
2009 Frihauf J, Fekete E, Zorrilla E. Maternal high-fat diet increases adiposity and glucose intolerance in adult offspring of obesity-resistant (DR) rats Appetite. 52: 833. DOI: 10.1016/j.appet.2009.04.078  0.749
2009 Fekete E, Cottone P, Frihauf J, Sabino V, Leos B, Zorrilla E. Central urocortin 2 anorexia is attenuated by high fat diet access and obesity risk genotype in female rats Appetite. 52: 831. DOI: 10.1016/j.appet.2009.04.071  0.78
2008 Mayorov AV, Amara N, Chang JY, Moss JA, Hixon MS, Ruiz DI, Meijler MM, Zorrilla EP, Janda KD. Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice. Proceedings of the National Academy of Sciences of the United States of America. 105: 17487-92. PMID 18981425 DOI: 10.1073/Pnas.0711808105  0.317
2008 Cottone P, Sabino V, Steardo L, Zorrilla EP. Intermittent access to preferred food reduces the reinforcing efficacy of chow in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 295: R1066-76. PMID 18667718 DOI: 10.1152/ajpregu.90309.2008  0.806
2008 Lu X, Ross B, Sanchez-Alavez M, Zorrilla EP, Bartfai T. Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests. Neuropeptides. 42: 387-97. PMID 18554714 DOI: 10.1016/J.Npep.2008.04.009  0.354
2008 Richardson HN, Zhao Y, Fekete EM, Funk CK, Wirsching P, Janda KD, Zorrilla EP, Koob GF. MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist. Pharmacology, Biochemistry, and Behavior. 88: 497-510. PMID 18031798 DOI: 10.1016/j.pbb.2007.10.008  0.819
2008 Specio SE, Wee S, O'Dell LE, Boutrel B, Zorrilla EP, Koob GF. CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats. Psychopharmacology. 196: 473-82. PMID 17965976 DOI: 10.1007/S00213-007-0983-9  0.771
2008 Cottone P, Sabino V, Steardo L, Zorrilla EP. Opioid-dependent anticipatory negative contrast and binge-like eating in rats with limited access to highly preferred food. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 524-35. PMID 17443124 DOI: 10.1038/sj.npp.1301430  0.824
2007 Tabarin A, Diz-Chaves Y, Consoli D, Monsaingeon M, Bale TL, Culler MD, Datta R, Drago F, Vale WW, Koob GF, Zorrilla EP, Contarino A. Role of the corticotropin-releasing factor receptor type 2 in the control of food intake in mice: a meal pattern analysis. The European Journal of Neuroscience. 26: 2303-14. PMID 17953621 DOI: 10.1111/j.1460-9568.2007.05856.x  0.618
2007 George O, Ghozland S, Azar MR, Cottone P, Zorrilla EP, Parsons LH, O'Dell LE, Richardson HN, Koob GF. CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats. Proceedings of the National Academy of Sciences of the United States of America. 104: 17198-203. PMID 17921249 DOI: 10.1073/Pnas.0707585104  0.792
2007 Zhao Y, Valdez GR, Fekete EM, Rivier JE, Vale WW, Rice KC, Weiss F, Zorrilla EP. Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats. The Journal of Pharmacology and Experimental Therapeutics. 323: 846-54. PMID 17855476 DOI: 10.1124/Jpet.107.123208  0.813
2007 Zhao Y, Weiss F, Zorrilla EP. Remission and resurgence of anxiety-like behavior across protracted withdrawal stages in ethanol-dependent rats. Alcoholism, Clinical and Experimental Research. 31: 1505-15. PMID 17760785 DOI: 10.1111/J.1530-0277.2007.00456.X  0.617
2007 Cottone P, Sabino V, Nagy TR, Coscina DV, Zorrilla EP. Feeding microstructure in diet-induced obesity susceptible versus resistant rats: central effects of urocortin 2. The Journal of Physiology. 583: 487-504. PMID 17627984 DOI: 10.1113/Jphysiol.2007.138867  0.82
2007 Chu K, Koob GF, Cole M, Zorrilla EP, Roberts AJ. Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout. Pharmacology, Biochemistry, and Behavior. 86: 813-21. PMID 17482248 DOI: 10.1016/J.Pbb.2007.03.009  0.611
2007 Sabino V, Cottone P, Steardo L, Schmidhammer H, Zorrilla EP. 14-Methoxymetopon, a highly potent mu opioid agonist, biphasically affects ethanol intake in Sardinian alcohol-preferring rats. Psychopharmacology. 192: 537-46. PMID 17345066 DOI: 10.1007/s00213-007-0746-7  0.815
2007 Zorrilla EP, Brennan M, Sabino V, Lu X, Bartfai T. Galanin type 1 receptor knockout mice show altered responses to high-fat diet and glucose challenge. Physiology & Behavior. 91: 479-85. PMID 17223141 DOI: 10.1016/J.Physbeh.2006.11.011  0.654
2007 Fekete EM, Zorrilla EP. Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Frontiers in Neuroendocrinology. 28: 1-27. PMID 17083971 DOI: 10.1016/j.yfrne.2006.09.002  0.749
2007 Cottone P, Sabino V, Steardo L, Zorrilla EP. FG 7142 specifically reduces meal size and the rate and regularity of sustained feeding in female rats: evidence that benzodiazepine inverse agonists reduce food palatability. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 1069-81. PMID 17077811 DOI: 10.1038/sj.npp.1301229  0.829
2007 O'Dell LE, Chen SA, Smith RT, Specio SE, Balster RL, Paterson NE, Markou A, Zorrilla EP, Koob GF. Extended access to nicotine self-administration leads to dependence: Circadian measures, withdrawal measures, and extinction behavior in rats. The Journal of Pharmacology and Experimental Therapeutics. 320: 180-93. PMID 17050784 DOI: 10.1124/Jpet.106.105270  0.732
2007 Fekete EM, Inoue K, Zhao Y, Rivier JE, Vale WW, Szücs A, Koob GF, Zorrilla EP. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 1052-68. PMID 17019404 DOI: 10.1038/Sj.Npp.1301214  0.834
2007 Funk CK, Zorrilla EP, Lee MJ, Rice KC, Koob GF. Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biological Psychiatry. 61: 78-86. PMID 16876134 DOI: 10.1016/J.Biopsych.2006.03.063  0.828
2006 Sabino V, Cottone P, Koob GF, Steardo L, Lee MJ, Rice KC, Zorrilla EP. Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology. 189: 175-86. PMID 17047935 DOI: 10.1007/S00213-006-0546-5  0.821
2006 Zorrilla EP, Iwasaki S, Moss JA, Chang J, Otsuji J, Inoue K, Meijler MM, Janda KD. Vaccination against weight gain. Proceedings of the National Academy of Sciences of the United States of America. 103: 13226-31. PMID 16891413 DOI: 10.1073/Pnas.0605376103  0.309
2006 Chen A, Zorrilla E, Smith S, Rousso D, Levy C, Vaughan J, Donaldson C, Roberts A, Lee KF, Vale W. Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 5500-10. PMID 16707802 DOI: 10.1523/Jneurosci.3955-05.2006  0.369
2006 Richardson HN, Zorrilla EP, Mandyam CD, Rivier CL. Exposure to repetitive versus varied stress during prenatal development generates two distinct anxiogenic and neuroendocrine profiles in adulthood. Endocrinology. 147: 2506-17. PMID 16455779 DOI: 10.1210/en.2005-1054  0.542
2006 Chen SA, O'Dell LE, Hoefer ME, Greenwell TN, Zorrilla EP, Koob GF. Unlimited access to heroin self-administration: independent motivational markers of opiate dependence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2692-707. PMID 16452993 DOI: 10.1038/Sj.Npp.1301008  0.815
2006 Chen SA, O'Dell LE, Hoefer ME, Greenwell TN, Zorrilla EP, Koob GF. Erratum: Unlimited Access to Heroin Self-Administration: Independent Motivational Markers of Opiate Dependence Neuropsychopharmacology. 31: 2802-2802. DOI: 10.1038/Sj.Npp.1301058  0.78
2005 Tabarin A, Diz-Chaves Y, Chaves YD, Carmona Mdel C, Catargi B, Zorrilla EP, Roberts AJ, Coscina DV, Rousset S, Redonnet A, Parker GC, Inoue K, Ricquier D, Pénicaud L, Kieffer BL, et al. Resistance to diet-induced obesity in mu-opioid receptor-deficient mice: evidence for a "thrifty gene". Diabetes. 54: 3510-6. PMID 16306369 DOI: 10.2337/Diabetes.54.12.3510  0.35
2005 Zorrilla EP, Inoue K, Fekete EM, Tabarin A, Valdez GR, Koob GF. Measuring meals: structure of prandial food and water intake of rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 288: R1450-67. PMID 15637168 DOI: 10.1152/ajpregu.00175.2004  0.809
2005 Zorrilla EP, Inoue K, Valdez GR, Tabarin A, Koob GF. Leptin and post-prandial satiety: acute central leptin more potently reduces meal frequency than meal size in the rat. Psychopharmacology. 177: 324-35. PMID 15609069 DOI: 10.1007/s00213-004-1952-1  0.59
2005 Stinus L, Cador M, Zorrilla EP, Koob GF. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 90-8. PMID 15138444 DOI: 10.1038/Sj.Npp.1300487  0.636
2005 Ghozland S, Zorrilla E, Parsons L, Koob G. B63 EXTRACELLULAR CRF LEVELS IN THE CENTRAL NUCLEUS OF THE AMYGDALA AND ANXIETY-LIKE BEHAVIOR DURING NICOTINE WITHDRAWAL Behavioural Pharmacology. 16: S85-S86. DOI: 10.1097/00008877-200509001-00268  0.681
2005 Zorrilla EP, Koob GF. Chapter 2.4 The roles of urocortins 1, 2, and 3 in the brain Techniques in the Behavioral and Neural Sciences. 15: 179-203. DOI: 10.1016/S0921-0709(05)80013-6  0.62
2005 Monsaingeon M, Diz-Chaves Y, Zorrilla E, Kieffer B, Corcuff J, Roberts A, Koob G, Tabarin A. CO21 - Modulation du comportement alimentaire par le système opioïde endogène mu Annales D'Endocrinologie. 66: 398. DOI: 10.1016/S0003-4266(05)81822-0  0.418
2005 Valdez GR, Zorrilla EP, Koob GF. Homeostasis within the corticotropin-releasing factor system via CRF 2 receptor activation: A novel approach for the treatment of anxiety Drug Development Research. 65: 205-215. DOI: 10.1002/ddr.20024  0.602
2004 Zorrilla EP, Koob GF. The therapeutic potential of CRF1 antagonists for anxiety. Expert Opinion On Investigational Drugs. 13: 799-828. PMID 15212620 DOI: 10.1517/13543784.13.7.799  0.613
2004 Inoue K, Zorrilla EP, Tabarin A, Valdez GR, Iwasaki S, Kiriike N, Koob GF. Reduction of anxiety after restricted feeding in the rat: implication for eating disorders. Biological Psychiatry. 55: 1075-81. PMID 15158426 DOI: 10.1016/j.biopsych.2004.01.026  0.577
2004 Zorrilla EP, Reinhardt LE, Valdez GR, Inoue K, Rivier JE, Vale WW, Koob GF. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity. The Journal of Pharmacology and Experimental Therapeutics. 310: 1027-34. PMID 15115804 DOI: 10.1124/jpet.104.068676  0.671
2004 Tabarin A, DizChavez Y, Catargi B, Roberts A, Zorrilla E, Redonnet A, Coscina D, Inoue K, Kieffer B, Koob G. CO05 - Récepteur mu des opioïdes endogènes : une nouvelle cible dans le traitement de l’obésité ? Annales D'Endocrinologie. 65: 249. DOI: 10.1016/S0003-4266(04)95686-7  0.411
2003 Zorrilla EP, Taché Y, Koob GF. Nibbling at CRF receptor control of feeding and gastrocolonic motility. Trends in Pharmacological Sciences. 24: 421-7. PMID 12915052 DOI: 10.1016/S0165-6147(03)00177-9  0.613
2003 Valdez GR, Zorrilla EP, Rivier J, Vale WW, Koob GF. Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist. Brain Research. 980: 206-12. PMID 12867260 DOI: 10.1016/S0006-8993(03)02971-8  0.641
2003 Valdez GR, Zorrilla EP, Roberts AJ, Koob GF. Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. Alcohol (Fayetteville, N.Y.). 29: 55-60. PMID 12782246 DOI: 10.1016/S0741-8329(03)00020-X  0.666
2003 Inoue K, Valdez GR, Reyes TM, Reinhardt LE, Tabarin A, Rivier J, Vale WW, Sawchenko PE, Koob GF, Zorrilla EP. Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat. The Journal of Pharmacology and Experimental Therapeutics. 305: 385-93. PMID 12649393 DOI: 10.1124/Jpet.102.047712  0.643
2003 Zorrilla E, Fekete E, Mason B, Wirsching P, Janda K, Koob G. S.13.01 CRF1 antagonists for anxiety European Neuropsychopharmacology. 13: S130-S131. DOI: 10.1016/S0924-977X(03)91650-6  0.511
2002 Valdez GR, Roberts AJ, Chan K, Davis H, Brennan M, Zorrilla EP, Koob GF. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcoholism, Clinical and Experimental Research. 26: 1494-501. PMID 12394282 DOI: 10.1111/J.1530-0277.2002.Tb02448.X  0.645
2002 Zorrilla EP, Schulteis G, Ormsby A, Klaassen A, Ling N, McCarthy JR, Koob GF, De Souza EB. Urocortin shares the memory modulating effects of corticotropin-releasing factor (CRF): mediation by CRF1 receptors. Brain Research. 952: 200-10. PMID 12376180 DOI: 10.1016/S0006-8993(02)03345-0  0.588
2002 Zorrilla EP, Valdez GR, Nozulak J, Koob GF, Markou A. Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat. Brain Research. 952: 188-99. PMID 12376179 DOI: 10.1016/S0006-8993(02)03189-X  0.699
2002 Valdez GR, Inoue K, Koob GF, Rivier J, Vale W, Zorrilla EP. Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide. Brain Research. 943: 142-50. PMID 12088848 DOI: 10.1016/S0006-8993(02)02707-5  0.568
2001 Zorrilla EP, Valdez GR, Weiss F. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology. 158: 374-81. PMID 11797058 DOI: 10.1007/S002130100773  0.571
2001 Weiss F, Ciccocioppo R, Parsons LH, Katner S, Liu X, Zorrilla EP, Valdez GR, Ben-Shahar O, Angeletti S, Richter RR. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Annals of the New York Academy of Sciences. 937: 1-26. PMID 11458532 DOI: 10.1111/J.1749-6632.2001.Tb03556.X  0.694
2001 Zorrilla EP, Schulteis G, Ling N, Koob GF, De Souza EB. Performance-enhancing effects of CRF-BP ligand inhibitors. Neuroreport. 12: 1231-4. PMID 11338197 DOI: 10.1097/00001756-200105080-00035  0.575
2000 Richter RM, Zorrilla EP, Basso AM, Koob GF, Weiss F. Altered amygdalar CRF release and increased anxiety-like behavior in Sardinian alcohol-preferring rats: a microdialysis and behavioral study. Alcoholism, Clinical and Experimental Research. 24: 1765-72. PMID 11141034  0.537
2000 Spina MG, Basso AM, Zorrilla EP, Heyser CJ, Rivier J, Vale W, Merlo-Pich E, Koob GF. Behavioral effects of central administration of the novel CRF antagonist astressin in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 230-9. PMID 10693150 DOI: 10.1016/S0893-133X(99)00108-6  0.643
2000 Richter RM, Zorrilla EP, Basso AM, Koob GF, Weiss F. Altered Amygdalar CRF Release and Increased Anxiety-Like Behavior in Sardinian Alcohol-Preferring Rats: A Microdialysis and Behavioral Study Alcoholism: Clinical and Experimental Research. 24: 1765-1772. DOI: 10.1111/J.1530-0277.2000.Tb01979.X  0.712
1997 Halasz I, Rittenhouse PA, Zorrilla EP, Redei E. Sexually dimorphic effects of maternal adrenalectomy on hypothalamic corticotrophin-releasing factor, glucocorticoid receptor and anterior pituitary POMC mRNA levels in rat neonates. Brain Research. Developmental Brain Research. 100: 198-204. PMID 9205810 DOI: 10.1016/S0165-3806(97)00033-3  0.616
1995 Zorrilla EP, DeRubeis RJ, Redei E. High self-esteem, hardiness and affective stability are associated with higher basal pituitary-adrenal hormone levels. Psychoneuroendocrinology. 20: 591-601. PMID 8584600 DOI: 10.1016/0306-4530(95)00005-9  0.594
1994 Zorrilla EP, Redei E, DeRubeis RJ. Reduced cytokine levels and T-cell function in healthy males: relation to individual differences in subclinical anxiety. Brain, Behavior, and Immunity. 8: 293-312. PMID 7696716 DOI: 10.1006/Brbi.1994.1028  0.568
1994 Zorrilla EP, DeRubeis RJ, Redei E. Disposition Predictors Of Individual Differences In T-Cell Function And Cytokine Levels Neuropsychopharmacology. 11: 290-290. DOI: 10.1038/Sj.Npp.1380233  0.559
Show low-probability matches.